NON-SMALL CELL LUNG CANCER STAGE I
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE I explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE I trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a soy compound shield lungs from radiation damage?
Disease control Recruiting nowThis phase 2 trial tests whether adding BIO 300 (a synthetic soy compound) to standard radiation therapy can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease. About 25 participants will re…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE I
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
Blood test guides new attack on lung cancer return
Disease control Recruiting nowThis study uses a blood test to detect tiny amounts of cancer DNA left after standard treatment for early-stage non-small cell lung cancer. People whose blood shows this leftover cancer are at higher risk of the cancer coming back. The study tests whether the drug durvalumab can …
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE I
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 18, 2026 12:00 UTC